Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment …
Browse through Dermatology Advisor's home page to discover featured content, latest news, and treatment studies on topics in dermatology.
AAD Issues New Guidelines for Clinical Management of Acne …
2024年3月22日 · The American Academy of Dermatology (AAD) has issued updated guidelines for the clinical management of patients with acne vulgaris, which have been published in the Journal of the American Academy of Dermatology.. Systematic reviews to evaluate the effectiveness and safety of acne treatments approved by the United States Food and Drug Administration (FDA) were performed from May 2021 to ...
Secukinumab Reduces Hidradenitis Suppurativa Disease Severity
4 天之前 · Secukinumab significantly reduced disease severity in patients with moderate to severe hidradenitis suppurativa (HS), with improvements in the International Hidradenitis Suppurativa Severity Score System (IHS4) seen as early as 16 weeks and sustained through 52 weeks, according to a post hoc analysis of the SUNSHINE and SUNRISE trials.
Uremic Xerosis May Be Improved by Use of Emollient Containing …
5 天之前 · An emollient cream containing glycerol 15% and paraffin 10%, V0034CR, was associated with clinical improvement among patients with moderate to severe uremic xerosis when compared with a control vehicle, according to study results published in Dermatology and Therapy.. Investigators performed a phase 3, randomized, double-blind, vehicle-controlled study to assess the long-term efficacy ...
Overview of Diagnosis and Management of Seborrheic Dermatitis
2022年9月9日 · For patients with seborrheic dermatitis, blood test, dermatoscopy, histological exam, instrumental and/or laboratory evaluations are suggested.
Long-Term Dupilumab Is Safe, Effective for Atopic Dermatitis for …
2024年8月23日 · Included in the safety analysis were 2677 patients, of whom 60.2% were men. Mean (SD) patient age was 39.2 (13.4) years. The majority (82.4%) of patients continued treatment with dupilumab for at least 52 weeks and 12.5% continued treatment up to week 260 (5 years). Approximately half (48.4%) of patients completed both treatment and an end-of-study visit.
An Updated Review of Melasma Treatments - Dermatology Advisor
2022年8月26日 · A multimodality approach to treating melasma may be the most successful. An international team of researchers summarizes the available medical therapies for melasma and offers suggestions and recommendations for the use of these therapies in clinical practice.
2021 Guidelines of Rosacea Management - Dermatology Advisor
2021年9月13日 · The British Association of Dermatologists (BAD) published new 2021 guidelines for the management of patients with rosacea in the British Journal of Dermatology.In the report, the BAD guidelines outline recommendations for mitigating rosacea aggravation, classifying patients based on phenotypes, using topical and systemic therapies, and employing procedural interventions, among several other ...
Treatment of Moderate to Severe Atopic Dermatitis: Highlights …
From March 17 to 21, 2023, dermatologists gathered for the American Academy of Dermatology (AAD) Annual Meeting, where they discussed the latest research on the treatment and management of a range of inflammatory skin diseases and other conditions. In this article, Emma Guttman-Yassky, MD, PhD, discusses the most exciting research on the treatment of moderate to severe atopic dermatitis ...
Tinea Versicolor (pityriasis versicolor) - Dermatology Advisor
2019年3月13日 · Are You Confident of the Diagnosis? What you should be alert for in the history. History is suggestive when an individual reports an asymptomatic or minimally pruritic eruption that appears and/or recurs on the upper trunk and proximal arms, areas rich in sebaceous glands, in warm weather months.